OpGen Group Company Ares Genetics Demonstrates Feasibility of CLIA-compliant Next Generation Sequencing Workflow for Identification of Bacterial Pathogens and Antibiotic Resistance Markers

NEXT STORY
BridgeBio Pharma Expands Reach Into China and Other Major Asian Markets Through Strategic Collaboration With Perceptive Advisors-Founded Company, LianBio
PREV STORY
Pulmonary Devices Market Forecast to 2027 – COVID-19 Impact and Global Analysis by Type ; Application ; End User, and Geography
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Dynavax to Present at J.P. Morgan 36th Annual Healthcare Conference

BERKELEY, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ:DVAX) announced today ...

author_avatar
NASDAQ Market News

GRAIL Announces Data From Early Research Analyzing its High-Intensity Sequencing Approach

CHICAGO, June 03, 2017 (GLOBE NEWSWIRE) -- GRAIL, Inc., a life sciences company focused ...

author_avatar
NASDAQ Market News

Athenex Pharmaceutical Division and SunGen Pharma Announce Terbutaline Sulfate Injection Product Launch

BUFFALO, N.Y., Aug. 31, 2017 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical ...

author_avatar
NASDAQ Market News